GLAXF
Price
$19.77
Change
-$0.58 (-2.85%)
Updated
Sep 5 closing price
Capitalization
79.91B
NVSEF
Price
$130.25
Change
-$0.47 (-0.36%)
Updated
Sep 3 closing price
Capitalization
249.99B
Interact to see
Advertisement

GLAXF vs NVSEF

Header iconGLAXF vs NVSEF Comparison
Open Charts GLAXF vs NVSEFBanner chart's image
GSK
Price$19.77
Change-$0.58 (-2.85%)
Volume$7.83K
Capitalization79.91B
Novartis AG
Price$130.25
Change-$0.47 (-0.36%)
Volume$242
Capitalization249.99B
GLAXF vs NVSEF Comparison Chart in %
Loading...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLAXF vs. NVSEF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAXF is a Hold and NVSEF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (GLAXF: $19.77 vs. NVSEF: $130.25)
Brand notoriety: GLAXF and NVSEF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GLAXF: 518% vs. NVSEF: 1%
Market capitalization -- GLAXF: $79.91B vs. NVSEF: $249.99B
GLAXF [@Pharmaceuticals: Major] is valued at $79.91B. NVSEF’s [@Pharmaceuticals: Major] market capitalization is $249.99B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLAXF’s FA Score shows that 2 FA rating(s) are green whileNVSEF’s FA Score has 3 green FA rating(s).

  • GLAXF’s FA Score: 2 green, 3 red.
  • NVSEF’s FA Score: 3 green, 2 red.
According to our system of comparison, NVSEF is a better buy in the long-term than GLAXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLAXF’s TA Score shows that 5 TA indicator(s) are bullish while NVSEF’s TA Score has 6 bullish TA indicator(s).

  • GLAXF’s TA Score: 5 bullish, 4 bearish.
  • NVSEF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NVSEF is a better buy in the short-term than GLAXF.

Price Growth

GLAXF (@Pharmaceuticals: Major) experienced а -0.93% price change this week, while NVSEF (@Pharmaceuticals: Major) price change was -0.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.93%. For the same industry, the average monthly price growth was +4.01%, and the average quarterly price growth was +13.35%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.93% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($250B) has a higher market cap than GLAXF($79.9B). NVSEF has higher P/E ratio than GLAXF: NVSEF (18.99) vs GLAXF (17.79). NVSEF YTD gains are higher at: 35.536 vs. GLAXF (17.504). NVSEF has higher annual earnings (EBITDA): 22.7B vs. GLAXF (8.61B). NVSEF has more cash in the bank: 7B vs. GLAXF (3.62B). GLAXF has less debt than NVSEF: GLAXF (17.4B) vs NVSEF (32.6B). NVSEF has higher revenues than GLAXF: NVSEF (55.2B) vs GLAXF (31.6B).
GLAXFNVSEFGLAXF / NVSEF
Capitalization79.9B250B32%
EBITDA8.61B22.7B38%
Gain YTD17.50435.53649%
P/E Ratio17.7918.9994%
Revenue31.6B55.2B57%
Total Cash3.62B7B52%
Total Debt17.4B32.6B53%
FUNDAMENTALS RATINGS
GLAXF vs NVSEF: Fundamental Ratings
GLAXF
NVSEF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
10025
SMR RATING
1..100
4029
PRICE GROWTH RATING
1..100
5546
P/E GROWTH RATING
1..100
2678
SEASONALITY SCORE
1..100
575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLAXF's Valuation (6) in the null industry is in the same range as NVSEF (16). This means that GLAXF’s stock grew similarly to NVSEF’s over the last 12 months.

NVSEF's Profit vs Risk Rating (25) in the null industry is significantly better than the same rating for GLAXF (100). This means that NVSEF’s stock grew significantly faster than GLAXF’s over the last 12 months.

NVSEF's SMR Rating (29) in the null industry is in the same range as GLAXF (40). This means that NVSEF’s stock grew similarly to GLAXF’s over the last 12 months.

NVSEF's Price Growth Rating (46) in the null industry is in the same range as GLAXF (55). This means that NVSEF’s stock grew similarly to GLAXF’s over the last 12 months.

GLAXF's P/E Growth Rating (26) in the null industry is somewhat better than the same rating for NVSEF (78). This means that GLAXF’s stock grew somewhat faster than NVSEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLAXFNVSEF
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
43%
Momentum
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
56%
MACD
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
50%
Advances
ODDS (%)
Bullish Trend 19 days ago
65%
Bullish Trend 19 days ago
51%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
61%
Aroon
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRWD417.635.17
+1.25%
CrowdStrike Holdings
IRTC181.05-1.12
-0.61%
iRhythm Technologies
SSP2.95-0.06
-1.99%
EW Scripps Company (The)
COLL38.32-0.91
-2.32%
Collegium Pharmaceutical
ZOOZ2.36-0.38
-13.87%
ZOOZ Power Ltd

GLAXF and

Correlation & Price change

A.I.dvisor tells us that GLAXF and OPHLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLAXF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
-2.85%
OPHLY - GLAXF
9%
Poorly correlated
+0.52%
GIKLY - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
3%
Poorly correlated
-3.57%
NVSEF - GLAXF
-0%
Poorly correlated
N/A
OPHLF - GLAXF
-2%
Poorly correlated
N/A
More

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
N/A
SNYNF - NVSEF
26%
Poorly correlated
+0.54%
GIKLY - NVSEF
7%
Poorly correlated
N/A
KYKOF - NVSEF
5%
Poorly correlated
N/A
OPHLY - NVSEF
2%
Poorly correlated
+0.52%
GLAXF - NVSEF
1%
Poorly correlated
-2.85%
More